Company: CXDO
Filing Date: 2025-10-20
Form Type: DEF 14A
Source: 0001654954-25-011941
Chunk: 7

Company: Crexendo, Inc.
Filing Date: 2025-10-20
Form: DEF 14A
Chunk 7
---
 Company’s named executive officers, must receive the affirmative vote of a majority of the voting power of the stock issued and outstanding and present in person or by proxy at the meeting and entitled to vote thereon to be approved. Abstentions are considered votes cast and, thus, will have the same effect as a vote “against” the proposal. Broker non-votes will have no effect on the outcome of this proposal.

Proposal III - Advisory approval of the frequency of advisory approval of compensation of the Company’s named executive officers, must receive the affirmative vote of a majority of the voting power of the stock issued and outstanding and present in person or by proxy at the meeting and entitled to vote thereon to be approved. Abstentions are considered votes cast and, thus, will have the same effect as a vote “against” the proposal. Broker non-votes will have no effect on the outcome of this proposal.

Proposal IV – Ratification of Appointment of Urish Popeck & Co., LLC as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025, must receive the affirmative vote of a majority of the voting power of the stock issued and outstanding and present in person or by proxy at the meeting and entitled to vote thereon to be approved. Abstentions are considered votes cast and, thus, will have the same effect as a vote “against” the proposal. Broker non-votes will have no effect on the outcome of this proposal.

Our Voting Recommendations

When proxies are properly dated, executed and returned, the shares represented by such proxies will be voted at the Annual Meeting in accordance with the instructions of the stockholder. However, if no specific instructions are given, the shares will be voted in accordance with the following recommendations of our Board:

| · | “FOR” the election of the six (6) directors nominated by our board of directors and named in the proxy statement (Proposal I);                                                    |
| · | “FOR” advisory approval of the proposal for compensation of the Company’s named executive officers (Proposal II);                                                                 |
| · | “FOR” advisory approval of the frequency of advisory approval of compensation of the Company’s named executive officers (Proposal III); and                                       |
| · | “FOR” the ratification of appointment of Urish Popeck & Co., LLC as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (Proposal IV). |

No Dissenters’ Rights

Stockholders of the Company have no rights of appraisal or similar